Olga Anagnostou

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

Richard T. Davey, Eduardo Fernández‐Cruz, Norman Markowitz et al. · The Lancet Respiratory Medicine · 2019 · 134 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +12

Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: is elimination possible in a high‐prevalence setting?

Ilias Gountas, Vana Sypsa, Olga Anagnostou et al. · Addiction · 2017 · 51 citations · Full text

Pharmacy, Infectious Disease Control, Preventive Medicine +17

Significant epidemiological changes in chronic hepatitis C infection: results of the nationwide HEPNET-GREECE cohort study.

M. Raptopoulou, Giota Touloumi, Dimitrios Tzourmakliotis et al. · PubMed · 2011 · 34 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +15

Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C

Spilios Manolakopoulos, Melanie Deutsch, Olga Anagnostou et al. · Liver International · 2010 · 28 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

Ruth Lynfield, Marcelo Losso, Richard T. Davey et al. · Open Forum Infectious Diseases · 2017 · 18 citations · Full text

Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +6